<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00157846</url>
  </required_header>
  <id_info>
    <org_study_id>CEN_G_CA_1</org_study_id>
    <nct_id>NCT00157846</nct_id>
  </id_info>
  <brief_title>X-Change HF - Exchange of the Existing Pacemaker/ICD in Bradycardia Patients Suffering From Heart Failure</brief_title>
  <official_title>Exchange of the Existing Pacemaker/ICD in Bradycardia Patients Suffering From Heart Failure to Investigate the Effect of Preventive Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Bakken Research Center</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medtronic Bakken Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of X-Change HF is to estimate the effect of biventricular stimulation in patients
      who need antibradycardia ventricular stimulation (more than 80%); are eligible for the
      exchange of an old pacemaker or implantable cardioverter defibrillator (ICD); and have
      ventricular dysfunction (left ventricular ejection fraction [LVEF] &lt; 35%). All patients
      eligible for participation in the study will be upgraded with a cardiac resynchronization
      therapy (CRT)-device and receive either right ventricular or biventricular stimulation in a
      crossover protocol. The endpoint is functional performance measured by spiroergometry.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Due to existing evidence eligible patients receive CRT treatment in first place
  </why_stopped>
  <start_date>October 2003</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiopulmonary performance measured by spiroergometry</measure>
    <time_frame>Baseline to 7 months post-implant</time_frame>
    <description>Maximal oxygen uptake (Vo2 max [ml/kg/min])</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Left ventricular end diastolic diameter (LVEDD [mm])</measure>
    <time_frame>Baseline to 7 months post-implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>N-terminal prohormone brain natriuretic peptide (NT-proBNP) [pg/ml]</measure>
    <time_frame>Baseline to 7 months post-implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular ejection fraction (LVEF [%])</measure>
    <time_frame>Baseline to 7 months post-implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New York Heart Association (NYHA) Class</measure>
    <time_frame>Baseline to 7 months post-implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of rhythm disturbances: atrial arrhythmias (amount and duration [h/day])</measure>
    <time_frame>Baseline to 7 months post-implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of rhythm disturbances: ventricular arrhythmias (amount and duration [h/day])</measure>
    <time_frame>Baseline to 7 months post-implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability [ms]</measure>
    <time_frame>Baseline to 7 months post implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of hospitalizations because of heart failure (amount and duration [days])</measure>
    <time_frame>Baseline to 7 months post-implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiopulmonary performance measured by spiroergometry: Oxygen uptake at the anaerobic threshold (VO2 AT [s])</measure>
    <time_frame>Baseline to 7 months post-implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Baseline to 7 months post-implant</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Heart Failure, Congestive</condition>
  <arm_group>
    <arm_group_label>BiV Pacing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Biventricular pacing for 3 months, subsequently right ventricular pacing for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RV Stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Right ventricular pacing for 3 months, subsequently biventricular pacing for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CRT-P or CRT-D Device</intervention_name>
    <description>Upgrade from ICD or pacemaker to CRT-D/CRT-P (Insync III, Insync Marquis, Insync Sentry, Insync Maximo, Concerto)</description>
    <arm_group_label>BiV Pacing</arm_group_label>
    <arm_group_label>RV Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Implanted dual-chamber pacemaker or ICD system with replacement indication

               -  Because of battery end of life

               -  Because of upgrade from pacemaker to ICD system

                    -  predominant sinus rhythm (paroxysmal atrial fibrillation [AF] &lt; 2 hours/day)

                    -  predominant ventricular stimulation (&gt;= 80%)

                    -  NYHA Class II-III

                    -  LVEF &lt;= 35%

        Exclusion Criteria:

          -  NYHA Class IV

          -  Life expectancy of less than one year because of accompanying diseases

          -  Myocardial infarction less than 3 months old

          -  Cardiac surgery less than 3 months

               -  Bypass

               -  Valve surgery

               -  Percutaneous transluminal coronary angioplasty (PTCA)

          -  Thoracotomy, for implant of an epicardial LV electrode

          -  Medical circumstances that make participation and compliance impossible

          -  Patients who are not willing or able to give written consent for their study
             participation

          -  Participation in another study

          -  Patients less than 18 years old

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Lawo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Berufsgenossenschaftliche Kliniken Bergmannsheil Bochum</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinikum Augsburg I. Medizinische Klinik</name>
      <address>
        <city>Augsburg</city>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite Campus Virchow-Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unfallkrankenhaus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ev. Freikirchliches KH Bernau und Herzzentrum Brandenburg</name>
      <address>
        <city>Bernau</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Berufsgenossenschaftliche Kliniken Bergmannsheil</name>
      <address>
        <city>Bochum</city>
        <zip>44789</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches Kreiskrankenhaus</name>
      <address>
        <city>Friedrichshafen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Georg-August-Universität Göttingen</name>
      <address>
        <city>Göttingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St.-Vincentius Klinken</name>
      <address>
        <city>Karlsruhe</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Märkische Kliniken GmbH Klinikum Luedenscheid</name>
      <address>
        <city>Luedenscheid</city>
        <zip>58515</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Reinbek St. Adolf Stift</name>
      <address>
        <city>Reinbek b. Hamburg</city>
        <zip>21465</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 10, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>February 14, 2017</last_update_submitted>
  <last_update_submitted_qc>February 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>LVEF &lt; 35%</keyword>
  <keyword>Bradycardia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

